|Videos|August 12, 2016

How Can Human Factors Engineering Help Prevent Infections?

Sarah Krein, PhD, RN, health services researcher and research scientist at VA Ann Arbor Healthcare System, explains how the new concept of human factors engineering can be used in infection prevention.

Sarah Krein, PhD, RN, health services researcher and research scientist at VA Ann Arbor Healthcare System, explains how the new concept of human factors engineering can be used in infection prevention.

Interview Transcript (slightly modified for readability).

“Human factors engineering is a relatively new field, especially within infection prevention. We’ve been seeing it used in patient safety for several years now. There [are] examples of human factors engineering and redesign efforts related to things like electronic medical record implementation, [and] the use of different types of technologies, such as defibrillators and IV pumps. There [have] been studies around safety in the operating room environment.

[Human factors engineering] is still a relatively new concept, but we’re beginning to see some examples in which it’s being utilized to improve the maintenance of central lines. There’s also some work that’s being done looking at implementation of bundles related to [Clostridium difficile] infection and prevention and I think we’re going to be seeing more utilization as we go forward around other infectious diseases and transmission of disease. For example, in work that I’m currently involved with, we’re looking at how we can use human factors to help us better understand the use of personal protective equipment: both personal protective equipment as it applies to the type of equipment you would use for Ebola, for example, but also, just general use of personal protective equipment in everyday healthcare settings.”


Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.